Insider Transactions in Q1 2024 at Solid Biosciences Inc. (SLDB)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2024
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
139
-1.62%
|
$973
$7.99 P/Share
|
|
Jan 27
2024
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
3,883
+3.93%
|
-
|
|
Jan 27
2024
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Indirect |
388
+4.34%
|
-
|
|
Jan 11
2024
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
3,410,713
+33.29%
|
$17,053,565
$5.53 P/Share
|
|
Jan 11
2024
|
Bain Capital Life Sciences Investors, LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
904,160
+18.31%
|
$4,520,800
$5.53 P/Share
|
|
Jan 11
2024
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
904,160
+17.74%
|
$4,520,800
$5.53 P/Share
|
|
Jan 11
2024
|
Adam Koppel |
BUY
Grant, award, or other acquisition
|
Indirect |
904,160
+18.31%
|
$4,520,800
$5.53 P/Share
|
|
Jan 09
2024
|
Kevin Tan CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
3,935
-29.71%
|
$31,480
$8.2 P/Share
|
|
Jan 09
2024
|
Kevin Tan CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+45.93%
|
-
|
|
Jan 03
2024
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
1,142
-12.27%
|
$5,710
$5.3 P/Share
|
|
Jan 03
2024
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,993
+24.33%
|
-
|
|
Jan 03
2024
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
15,570
+13.48%
|
-
|